Member Company


emocog provides a platform-based digital therapeutics solution related to emotion and cognition. Our leading product, Cogthera, is a SaMD which provides an all-in-one solution for the treatment, management, screening of patients with SCD (Subjective Cognitive Decline) and MCI (Mild Cognitive Impairment). Cogthera integrates AI technology to provide personalized daily testing and training regimens in order to prevent the progression of SCD and MCI into dementia. Our products are designed and implemented with a focus on user engagement and easy-to-use UX/UI integrations which facilitate the seamless delivery of our digital solutions.

Copyright © 2024 Digital Therapeutics Alliance™